# Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn

> **NCT01718639** · PHASE4 · COMPLETED · sponsor: **InQpharm Group** · enrollment: 41 (actual)

## Conditions studied

- Postprandial Heartburn

## Interventions

- **DEVICE:** IQP-LH-101 tablet
- **DEVICE:** IQP-LH-101 liquid
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01718639
- **Lead sponsor:** InQpharm Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2013-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01718639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01718639, "Safety and Efficacy of IQP-LH-101 in Postprandial Heartburn". Retrieved via AI Analytics 2026-09-21 from https://api.ai-analytics.org/clinical/NCT01718639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*